PRednisone Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of VEGFR -TKI
Condition(s):Metastatic Renal CancerLast Updated:January 16, 2018Terminated
Hide Studies Not Open or Pending
Condition(s):Metastatic Renal CancerLast Updated:January 16, 2018Terminated
Condition(s):Chronic Graft-versus-host DiseaseLast Updated:April 2, 2020Completed
Condition(s):Comparative Study; Immunosuppressive AgentsLast Updated:August 17, 2010Completed
Condition(s):Prostate CancerLast Updated:December 1, 2020Completed
Condition(s):Cytomegalovirus InfectionsLast Updated:August 22, 2013Unknown status
Condition(s):BK Virus InfectionLast Updated:August 15, 2016Completed
Condition(s):Acute Lymphoblastic LeukemiaLast Updated:September 21, 2023Completed
Condition(s):LymphomaLast Updated:August 10, 2017Completed
Condition(s):Organ Transplantation, Renal TransplantationLast Updated:August 9, 2018Completed
Condition(s):Graft Dysfunction; Interstitial FibrosisLast Updated:August 8, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.